XML 94 R38.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Alcon subsidiaries
 12 Months Ended
Dec. 31, 2019
Disclosure Of Separate Financial Statements [Abstract]  
Alcon subsidiaries Alcon subsidiaries
The following table lists the Alcon legal entities with Total assets or Net sales to third parties in excess of $5 million included in the Consolidated Financial Statements at and for the year ended December 31, 2019, respectively. The equity interest percentage shown in the table represents Alcon's share in voting rights in those entities. Unless otherwise stated, each entity has share capital consisting of equity held directly by the Company or another of its consolidated subsidiaries.


 
Country of organization/Entity name
Place of business
Equity
interest

Argentina
 
 
Alcon Laboratorios Argentina S.A.
Buenos Aires
100
%
Australia
 
 
Alcon Laboratories (Australia) Pty Ltd
Frenchs Forest, NSW
100
%
Austria
 
 
Alcon Ophthalmika GmbH
Wein
100
%
Belgium
 
 
Alcon Laboratories Belgium BVBA
Puurs
100
%
N.V. Alcon S.A.
Vilvoorde
100
%
Canada
 
 
Alcon Canada Inc.
Mississauga, Ontario
100
%
Chile
 
 
Alcon Laboratorios Chile Ltd.
Santiago de Chile
100
%
China
 
 
Alcon (China) Ophthalmic Product Co., Ltd.
Beijing
100
%
Alcon Hong Kong Limited
Hong Kong
100
%
Colombia
 
 
Laboratorios Alcon de Colombia S.A.
Santafé de Bogotá
100
%
Czech Republic
 
 
Alcon Pharmaceuticals (Czech Republic) s.r.o.
Prague
100
%
Denmark
 
 
Alcon Nordic A/S
Copenhagen
100
%
Dominican Republic
 
 
Alcon Dominicana, SRL
Santo Domingo
100
%
Ecuador
 
 
AlconLab Ecuador S.A.
Quito
100
%
France
 
 
Laboratoires Alcon S.A.S.
Rueil-Malmaison
100
%
Germany
 
 
Alcon Pharma GmbH
Freiburg im Breisgau
100
%
CIBA Vision GmbH
Grosswallstadt
100
%
WaveLight GmbH
Erlangen
100
%
Greece
 
 
Alcon Laboratories Hellas- Single Member Commercial and Industrial S.A.C.I.
Maroussi, Athens
100
%
Hungary
 
 
Alcon Hungary Pharmaceuticals Trading Limited Liability Company
Budapest
100
%
India
 
 
Alcon Laboratories (India) Private Limited
Bangalore
100
%
Indonesia
 
 
PT. CIBA Vision Batam
Batam
100
%
Ireland
 
 
Alcon Laboratories Ireland Limited
Cork City
100
%
Israel
 
 
Optonol Ltd.
Neve-Ilan
100
%
 
 
 


 
Country of organization/Entity name
Place of business
Equity
interest

Italy
 
 
Alcon Italia S.p.A.
Milano
100
%
Japan
 
 
Alcon Japan Ltd.
Tokyo
100
%
Malaysia
 
 
Alcon Laboratories (Malaysia) Sdn. Bhd.
Petaling Jaya
100
%
CIBA Vision Johor Sdn. Bhd.
Kuala Lumpur
100
%
Mexico
 
 
Alcon Laboratorios, S.A. de C.V.
Ciudad de Mexico
100
%
Morocco
 
 
Alcon Maroc SARL D´Associé Unique
Casablanca
100
%
Netherlands
 
 
Alcon Nederland B.V.
Arnhem
100
%
New Zealand
 
 
Alcon Laboratories (New Zealand) Ltd.
Auckland
100
%
Panama
 
 
Alcon Centroamerica S.A.
Panama City
100
%
Peru
 
 
Alcon Pharmaceutical del Peru S.A.
Lima
100
%
Philippines
 
 
Alcon Laboratories (Philippines), Inc.
Manila
100
%
Poland
 
 
Alcon Polska Sp. z o.o.
Warszawa
100
%
Portugal
 
 
Alcon Portugal-Produtos e Equipamentos Oftalmológicos Lda.
Porto Salvo
100
%
Puerto Rico
 
 
Alcon (Puerto Rico), Inc.
Cataño, PR
100
%
Romania
 
 
Alcon Romania S.R.L.
Bucharest
100
%
Russian Federation
 
 
Alcon Farmacevtika LLC
Moscow
100
%
Singapore
 
 
Alcon Pte Ltd
Singapore
100
%
Alcon Singapore Manufacturing Pte Ltd
Singapore
100
%
CIBA Vision Asian Manufacturing and Logistics Pte Ltd.
Singapore
100
%
South Africa
 
 
Alcon Laboratories (South Africa) (Pty) Ltd.
Midrand
100
%
South Korea
 
 
Alcon Korea Ltd.
Seoul
100
%
Spain
 
 
Alcon Healthcare S.A.
Barcelona
100
%
Switzerland
 
 
Alcon Inc.
Fribourg
100
%
Alcon Grieshaber AG
Schaffhausen
100
%
Alcon Management SA
Vernier
100
%
Alcon Pharmaceuticals Ltd.
Fribourg
100
%
Alcon Services AG
Fribourg
100
%
Alcon Switzerland SA
Risch
100
%
Thailand
 
 
Alcon Laboratories (Thailand) Limited
Bangkok
100
%
Turkey
 
 
Alcon Laboratuvarlari Ticaret A.S.
Istanbul
100
%
 
 
 


 
Country of organization/Entity name
Place of business
Equity
interest

Ukraine
 
 
Alcon Ukraine LLC
Kiev
100
%
United Kingdom
 
 
Alcon Eye Care UK Limited
Frimley/Camberley
100
%
United States of America
 
 
Alcon Finance Corporation
Wilminton, DE
100
%
Alcon Laboratories, Inc.
Wilminton, DE
100
%
Alcon RefractiveHorizons, LLC
Fort Worth, TX
100
%
Alcon Research, LLC
Fort Worth, TX
100
%
Alcon Vision, LLC
Fort Worth, TX
100
%
CIBA Vision, LLC
Duluth, GA
100
%
WaveLight, Inc.
Sterling, VA
100
%
ClarVista Medical, Inc.
Aliso Viejo, CA
100
%
PowerVision, Inc.
Fort Worth, TX
100
%
Tear Film Innovations, Inc.
Fort Worth, TX
100
%
TrueVision Systems, Inc.
Fort Worth, TX
100
%
Alcon Lensx, Inc.
Fort Worth, TX
100
%
The list below shows the principal Novartis legal entities containing assets, liabilities and results of operations attributable to the Alcon business with Total assets or Net sales to third parties in excess of $5 million included in the Consolidated Financial Statements.
Brazil(1)
Novartis Biociências S.A.
Mexico
Novartis Farmacéutica, S.A. de C.V.

(1) In accordance with the Separation and Distribution Agreement with Novartis, the separation from Novartis of the Alcon business in Brazil was delayed, and the Alcon business in Brazil remained in Novartis Biociências S.A. following the Spin-off.  On February 3, 2020, the Alcon business in Brazil was transferred from Novartis Biociências S.A. to Alcon Brasil Cuidados com a Saúde Ltda. (“Alcon Brazil”), and on February 4, 2020, Alcon acquired from Novartis 100% of the ownership interests of Alcon Brazil, thereby completing the delayed transfer of the Alcon business in Brazil from Novartis to Alcon.